- 7.3 million doses already approved by mid-August
- A total of around 26 million vaccine doses to be made available in Germany
- Pharmaceutical drug safety in focus: active temperature control is becoming increasingly important due to climate change
The logistics for distributing the current flu vaccines have started earlier this year than in 2020. Since there was a shortage of vaccines last autumn, especially at the beginning of the flu season, the Paul Ehrlich Institute approved 7.3 million vaccine doses by mid-August. This was significantly more than by the same point in the previous year. "Right from the start, we were able to transport more vaccines than in 2020," confirms Wolfgang P. Albeck, CEO of express delivery service provider trans-o-flex, which specialises in logistics solutions for pharmaceuticals and other high-value, sensitive goods. A total of around 26 million vaccine doses are to be available in Germany for this year’s flu season. "The majority are handed over to us by manufacturers in September, and usually at least 95% of the flu vaccines have been delivered by the end of October."
Like most vaccines, influenza vaccines are also highly temperature-sensitive and classified as requiring a cold chain. This is why they have to be transported between two and eight degrees Celsius. "With our trans-o-flex ThermoMed network, we deliver them nationwide on behalf of numerous manufacturers," Albeck continues. "To comply with the temperature specifications, shipping with trans-o-flex ThermoMed does not require expensive special packaging and cooling media, which increase the weight and thus the transport price and also have to be retrieved or disposed of at great expense. Instead, we actively control the maintenance of the temperature by regulating the temperature of our vehicles and transshipment centres, and at the same time ensure transparent documentation in a temperature history."
According to Albeck, active temperature control is gaining in importance, not least in view of climate change, and the demand for transport solutions for vaccines and other temperature-sensitive pharmaceuticals is steadily increasing. "The summers are getting warmer, the winters colder, the fluctuations in the weather more and more unpredictable. This is why the risk of transporting temperature-sensitive goods without temperature control has become almost incalculable." trans-o-flex has adapted to this development and is the only logistics service provider in Germany and Austria to have built up nationwide transport networks, with deliveries within 24 hours, in which sensitive goods are actively temperature-controlled and documented from the consignor to the consignee both in the so-called ambient range (15 to 25 degrees Celsius) and in the refrigerated range (2 to 8 degrees). Actively temperature-controlled shipments are also offered in other European countries via the EUROTEMP network.
trans-o-flex’s core areas of expertise are logistics solutions for the pharmaceutical, cosmetics and consumer electronics industries and other high-end, sensitive goods. The company has built up transport networks to carry goods at 15 to 25 degrees Celsius or 2 to 8 degrees Celsius actively temperature-controlled and documented in accordance with EU regulations for pharmaceuticals transport throughout Germany and Austria. These EU-GDPs require the highest standards for safety and security, cleanliness, reliability and transparency, from which all trans-o-flex customers benefit. trans-o-flex operates internationally via the networks EUROTEMP (temperature-controlled logistics) and EURODIS (in 36 European countries). In contrast to parcel and groupage services, trans-o-flex delivers parcels and pallets on a consolidated basis. trans-o-flex Express offers numerous express and time-slot deliveries, special services such as hazardous goods transportation (without minimum quantity regulation), consignment consolidation or direct deliveries. The range of services is complemented by warehousing, order picking and individual value-added services such as serialisation and deserialisation of pharmaceuticals. This means that the company covers the entire logistics chain from procurement through to fulfilment. The annual turnover of the trans-o-flex companies, which employ a total of around 1,954 people (FTE, end of 2020), amounted to around 515 million euros in 2020. More information is available at www.trans-o-flex.com
trans-o-flex Express GmbH
Telefon: +49 (6201) 988-0
Telefax: +49 (6201) 988-980
Telefon: +49 (6201) 988-134
Fax: +49 (6201) 988-343